Medicinova (MNOV) Common Equity (2010 - 2026)
Medicinova (MNOV) posted quarterly Common Equity of $41.6 million for Q4 2025, down 20.79% year-over-year from $52.5 million in Q4 2024, and down 5.41% quarter-over-quarter from $44.0 million in Q3 2025.
Medicinova (MNOV) Common Equity (2010 - 2026) Analysis & Trends
Medicinova (MNOV) has reported Common Equity for 16 consecutive years, with $41.6 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Common Equity fell 20.79% year-over-year to $41.6 million; the TTM figure through Dec 2025 stood at $41.6 million (down 20.79% YoY), while the FY2025 annual figure was $41.6 million, down 20.79% from the prior year.
- Common Equity eased to $41.6 million in Q4 2025 per MNOV's latest filing, from $44.0 million in the prior quarter.
- Across five years, Common Equity topped out at $92.4 million in Q1 2021 and bottomed at $41.6 million in Q4 2025.
- Historically, Common Equity has averaged $66.0 million across 5 years, with a median of $64.9 million in 2023.
- Annual changes were most pronounced in 2021 — Common Equity advanced 26.2% — and 2025, when it dropped 20.79%.
- Medicinova's Common Equity stood at $83.7 million in 2021, then declined by 16.06% to $70.2 million in 2022, then retreated by 11.2% to $62.4 million in 2023, then decreased by 15.83% to $52.5 million in 2024, then fell by 20.79% to $41.6 million in 2025.
- Business Quant data shows MNOV's Common Equity at $41.6 million in Q4 2025, $44.0 million in Q3 2025, and $46.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 6.76 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 5.17 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.35 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 757.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 9.79 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 22.38 Bn |
| 10 | Medicinova | 66.94 Mn | 66.94 Mn | 317,759.00 | 37.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 37.27 Mn |
| Dec 31, 2025 | 41.59 Mn |
| Sep 30, 2025 | 43.96 Mn |
| Jun 30, 2025 | 46.86 Mn |
| Mar 31, 2025 | 49.93 Mn |
| Dec 31, 2024 | 52.50 Mn |
| Sep 30, 2024 | 55.07 Mn |
| Jun 30, 2024 | 57.41 Mn |
| Mar 31, 2024 | 59.83 Mn |
| Dec 31, 2023 | 62.38 Mn |
| Sep 30, 2023 | 64.67 Mn |
| Jun 30, 2023 | 65.18 Mn |
| Mar 31, 2023 | 67.73 Mn |
| Dec 31, 2022 | 70.24 Mn |
| Sep 30, 2022 | 73.11 Mn |
| Jun 30, 2022 | 76.61 Mn |
| Mar 31, 2022 | 80.36 Mn |
| Dec 31, 2021 | 83.68 Mn |
| Sep 30, 2021 | 86.48 Mn |
| Jun 30, 2021 | 89.23 Mn |